Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $7,154,747 |
| Sells | 0 | $0 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 22 Nov 2024 09:00 | LCTX | Lineage Cell Therapeutics Inc | CULLEY BRIAN M | President and CEO | 21 Nov 2024 | Purchase | 40,000 | 0.6 | 24,000 | D |
| 19 Aug 2024 18:24 | LCTX | Lineage Cell Therapeutics Inc | HOWE JILL ANN | Chief Financial Officer | 16 Aug 2024 | Purchase | 10,500 | 0.89 | 9,345 | D |
| 28 May 2024 09:11 | LCTX | Lineage Cell Therapeutics Inc | CULLEY BRIAN M | President and CEO | 24 May 2024 | Purchase | 10,000 | 1.05 | 10,500 | D |
| 08 Feb 2024 19:00 | LCTX | Lineage Cell Therapeutics Inc | BAILEY DON M | Director | 08 Feb 2024 | Purchase | 96,155 | 1.04 | 100,001 | I |
| 08 Feb 2024 18:58 | LCTX | Lineage Cell Therapeutics Inc | BROADWOOD PARTNERS, L.P. | Director , 10% | 06 Feb 2024 | Purchase | 6,730,770 | 1.04 | 7,000,001 | D |
| 02 Jan 2024 19:08 | LCTX | Lineage Cell Therapeutics Inc | JAYASURIYA ANULA | Director | 29 Dec 2023 | Purchase | 10,000 | 1.09 | 10,900 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)